| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.19.8.1986 |
| P8608 | Fatcat ID | release_w2hdiz65xnda7atpebicyskoqm |
| P698 | PubMed publication ID | 10446082 |
| P50 | author | Albert Hofman | Q30121906 |
| P2093 | author name string | C D Stehouwer | |
| M L Bots | |||
| C G Schalkwijk | |||
| J C Witteman | |||
| A E Hak | |||
| I C Westendorp | |||
| K H Polderman | |||
| P433 | issue | 8 | |
| P921 | main subject | obesity | Q12174 |
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 1986-1991 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women | |
| P478 | volume | 19 |
| Q80938093 | -717A>G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing atherosclerosis study |
| Q57750270 | A prospective study of the relationship between body mass index and cataract extraction among US women and men |
| Q37220318 | A useful predictor of early atherosclerosis in obese children: serum high-sensitivity C-reactive protein |
| Q44495933 | Abdominal fat mass is associated with adaptive immune activation: the CODAM Study |
| Q61762737 | Adipose Tissue Interleukin-18 mRNA and Plasma Interleukin-18: Effect of Obesity and Exercise* |
| Q33570915 | Adiposity and pathogen exposure predict C-reactive protein in Filipino women |
| Q36703010 | Adiposity is associated with endothelial activation in healthy 2-3 year-old children. |
| Q83324520 | Altered expression and glycosylation of plasma proteins in rheumatoid arthritis |
| Q26773580 | An Evolutionary Perspective of Nutrition and Inflammation as Mechanisms of Cardiovascular Disease |
| Q43781831 | Association of C-reactive protein with markers of prevalent atherosclerotic disease |
| Q36498281 | Association of Periodontal Diseases with Elevation of Serum C-reactive Protein and Body Mass Index |
| Q47373856 | Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction |
| Q81203889 | Atherogenic inflammatory and oxidative stress markers in relation to overweight values in male former athletes |
| Q33938878 | Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training |
| Q51363416 | Body composition, C-reactive protein, carotid artery remodeling and subclinical atherosclerosis in a general Taiwanese population. |
| Q44969867 | Body fat and C-reactive protein levels in healthy non-obese men. |
| Q37737166 | Breastfeeding, overweight status, and inflammation |
| Q38473714 | Bringing JUPITER down to earth |
| Q84522875 | C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese |
| Q28192240 | C-reactive protein and cardiovascular disease: a review of risk prediction and interventions |
| Q47182880 | C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss |
| Q44716954 | C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease |
| Q35158958 | C-reactive protein and subclinical cardiovascular disease among African-Americans: (the Jackson Heart Study). |
| Q39789380 | C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort |
| Q37097920 | C-reactive protein genotype affects exercise training-induced changes in insulin sensitivity |
| Q44594411 | C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol |
| Q37777888 | C-reactive protein is a mediator of cardiovascular disease |
| Q44489100 | C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease |
| Q37148493 | CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers |
| Q51497326 | Calcium supplementation does not affect CRP levels in postmenopausal women--a randomized controlled trial. |
| Q39725721 | Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome |
| Q37849235 | Chronic inflammation is correlated with percentage of body fat independent of the burden of infection |
| Q46988914 | Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters |
| Q35198206 | Co-morbidity in rheumatoid arthritis |
| Q34427072 | Coronary microvascular dysfunction in diabetes mellitus: A review |
| Q41003732 | Cross-sectional population associations between detailed adiposity measures and C-reactive protein levels at age 6 years: the Generation R Study |
| Q37431527 | Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. |
| Q33728315 | Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies |
| Q36403750 | Does C-reactive protein contribute to atherothrombosis via oxidant-mediated release of pro-thrombotic factors and activation of platelets? |
| Q38231269 | Dynamic interplay between metabolic syndrome and immunity. |
| Q36929124 | Effect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese Patients |
| Q43474748 | Effect of Danshen aqueous extract on serum hs-CRP, IL-8, IL-10, TNF-α levels, and IL-10 mRNA, TNF-α mRNA expression levels, cerebral TGF-β1 positive expression level and its neuroprotective mechanisms in CIR rats |
| Q44423210 | Effect of Metformin and Sulfonylurea on C-Reactive Protein Level in Well-Controlled Type 2 Diabetics with Metabolic Syndrome |
| Q44604233 | Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women. |
| Q46948236 | Effectiveness of weight loss in the elderly with type 2 diabetes mellitus |
| Q44123361 | Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. |
| Q33708384 | Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients |
| Q44599717 | Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans |
| Q44479466 | Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control |
| Q35813629 | Endothelial dysfunction, inflammation and diabetes |
| Q44477343 | Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children |
| Q35401476 | Genetic polymorphisms influence runners' responses to the dietary ingestion of antioxidant supplementation based on pequi oil (Caryocar brasiliense Camb.): a before-after study |
| Q35134241 | Heart disease in diabetic patients |
| Q26784205 | High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective |
| Q35902510 | High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population |
| Q46796856 | High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. |
| Q52629500 | Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: a Community Based Prospective Cohort Study. |
| Q74000020 | Higher levels of inflammation in obese children |
| Q43907982 | Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians |
| Q37422832 | Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome |
| Q35384977 | Inflamed by the flames? The impact of terrorism and war on immunity |
| Q36180883 | Inflammation and the etiology of type 2 diabetes |
| Q37198826 | Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population |
| Q35106116 | Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence |
| Q35918777 | Inflammation, insulin resistance, and obesity. |
| Q44494781 | Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. |
| Q28167207 | Insulin and insulin resistance: impact on blood pressure and cardiovascular disease |
| Q34486066 | Insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity |
| Q37690138 | Interaction of the endocrine system with inflammation: a function of energy and volume regulation |
| Q73392899 | Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must |
| Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
| Q36300182 | Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome |
| Q37125113 | Long-term C-reactive protein variability and prediction of metabolic risk |
| Q36148290 | Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery |
| Q43846907 | Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal |
| Q46956551 | Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin |
| Q27022800 | Mitochondrial genetics and obesity: evolutionary adaptation and contemporary disease susceptibility |
| Q46013144 | Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. |
| Q77463122 | Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo |
| Q78318718 | Obesity and cardiovascular disease |
| Q36758799 | Obesity and eye diseases |
| Q76394099 | Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome |
| Q44279278 | Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children |
| Q38126800 | Obesity-related cardiorenal disease: the benefits of bariatric surgery |
| Q37086968 | Perinatal nutrition programs neuroimmune function long-term: mechanisms and implications. |
| Q35304374 | Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans |
| Q73588894 | Plasma C-reactive protein concentrations in relation to 5-year body weight change among children: the Taipei Children Heart Study |
| Q33780863 | Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes. |
| Q35869041 | Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis |
| Q33627755 | Regression models for log-normal data: comparing different methods for quantifying the association between abdominal adiposity and biomarkers of inflammation and insulin resistance |
| Q44357481 | Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects |
| Q28177167 | Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors |
| Q46500229 | Relationship between C-reactive protein and arterial stiffness in an asymptomatic population |
| Q41333656 | Relationship between Sleep Duration and Risk Factors for Stroke. |
| Q74329569 | Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects |
| Q42805798 | Relationship of high-sensitive C-reactive protein with cardiovascular risk factors, clinical presentation and angiographic profile in patients with acute coronary syndrome: an Indian perspective |
| Q61565678 | Relationship of total and abdominal adiposity with CRP and IL-6 in women |
| Q36617129 | Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells |
| Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
| Q33559252 | Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study |
| Q46235517 | Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations |
| Q46784247 | Short-term changes in inflammatory response protein (hsCRP) do not parallel with changes in coronary vasoreactivity in obese men. |
| Q35998271 | Skeletal Muscle Insulin Resistance and Absence of Inflammation Characterize Insulin-Resistant Grade I Obese Women. |
| Q35871129 | Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics |
| Q44205504 | Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals |
| Q47131035 | Sonographically Assessed Intra-Abdominal Fat And Cardiometabolic Risk Factors in Adolescents with Extreme Obesity |
| Q57892545 | The effects of body acupuncture on obesity: anthropometric parameters, lipid profile, and inflammatory and immunologic markers |
| Q36737871 | The elusive link between high sensitivity C-reactive protein and carotid subclinical atherosclerosis in coronary artery bypass grafting candidates: a cross-sectional study |
| Q34020389 | The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people |
| Q43321595 | The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort |
| Q74845460 | The relation of body fat mass and distribution to markers of chronic inflammation |
| Q34514804 | The relationship between epicardial fat thickness and gestational diabetes mellitus |
| Q51362473 | The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China. |
| Q33704574 | The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population |
| Q33517923 | The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial |
| Q37202159 | The use of sibutramine in the management of obesity and related disorders: an update |
| Q36859053 | The usefulness of circulating adipokine levels for the assessment of obesity-related health problems |
| Q28344629 | Tumor necrosis factor receptor levels are associated with carotid atherosclerosis |
| Q38953433 | Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. |
| Q44548940 | Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing |
| Q35780390 | What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome |
| Q74552962 | [C-reactive protein as a coronary risk factor] |
Search more.